title: Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes.
abstract: In vivo insulin sensitivity can be assessed using "open loop" clamp or "closed loop" methods. Open loop clamp methods are static, and fix plasma glucose independently from plasma insulin. Closed loop methods are dynamic, and assess glucose disposal in response to a stable isotope labeled glucose tolerance test. Using PPARalpha(-/-) mice, open and closed loop assessments of insulin sensitivity/glucose disposal were compared. Indirect calorimetry done for the assessment of diurnal substrate utilization/metabolic flexibility showed that chow fed PPARalpha(-/-) mice had increased glucose utilization during the light (starved) cycle. Euglycemic clamps showed no differences in insulin stimulated glucose disposal, whether for chow or high fat diets, but did show differences in basal glucose clearance for chow fed PPARalpha(-/-) versus SV129J-wt mice. In contrast, the dynamic stable isotope labeled glucose tolerance tests reveal enhanced glucose disposal for PPARalpha(-/-) versus SV129J-wt, for chow and high fat diets. Area under the curve for plasma labeled and unlabeled glucose for PPARalpha(-/-) was approximately 1.7-fold lower, P < 0.01 during the stable isotope labeled glucose tolerance test for both diets. Area under the curve for plasma insulin was 5-fold less for the chow fed SV129J-wt (P < 0.01) but showed no difference on a high fat diet (0.30 +/- 0.1 for SV129J-wt vs. 0.13 +/- 0.10 for PPARalpha(-/-), P = 0.28). This study demonstrates that dynamic stable isotope labeled glucose tolerance test can assess "silent" metabolic phenotypes, not detectable by the static, "open loop", euglycemic or hyperglycemic clamps. Both open loop and closed loop methods may describe different aspects of metabolic inflexibility and insulin sensitivity.
authors.forename: Bhavapriya
authors.initials: B
authors.lastname: Vaitheesvaran
authors.forename: Fu-Yu
authors.initials: FY
authors.lastname: Chueh
authors.forename: Jun
authors.initials: J
authors.lastname: Xu
authors.forename: Chuck
authors.initials: C
authors.lastname: Trujillo
authors.forename: M F
authors.initials: MF
authors.lastname: Saad
authors.forename: W N P
authors.initials: WN
authors.lastname: Lee
authors.forename: Owen P
authors.initials: OP
authors.lastname: McGuinness
authors.forename: Irwin J
authors.initials: IJ
authors.lastname: Kurland
references.citation: Physiol Rev. 2006 Apr;86(2):465-514
references.pmid: 16601267
references.citation: Diabetes. 2006 Feb;55(2):390-7
references.pmid: 16443772
references.citation: Endocrinology. 2004 Mar;145(3):1087-95
references.pmid: 14670991
references.citation: Diabetes. 2000 May;49(5):677-83
references.pmid: 10905472
references.citation: Anal Biochem. 2003 Apr 15;315(2):238-46
references.pmid: 12689833
references.citation: Diabetes. 2006 Dec;55(12):3429-38
references.pmid: 17130489
references.citation: J Biol Chem. 2002 Dec 27;277(52):50237-44
references.pmid: 12176975
references.citation: Biochem Soc Trans. 1986 Oct;14(5):799-806
references.pmid: 3536635
references.citation: Cell Metab. 2006 Jan;3(1):35-45
references.pmid: 16399503
references.citation: Am J Med. 2006 May;119(5 Suppl 1):S10-6
references.pmid: 16563942
references.citation: Proc Nutr Soc. 1995 Mar;54(1):317-27
references.pmid: 7568263
references.citation: Diabetes. 2001 Dec;50(12):2809-14
references.pmid: 11723064
references.citation: Int J Obes (Lond). 2008 Dec;32 Suppl 7:S109-19
references.pmid: 19136979
references.citation: Diabetes. 2006 Dec;55(12):3372-80
references.pmid: 17130482
references.citation: Endocrinology. 2004 Apr;145(4):1662-7
references.pmid: 14670996
references.citation: Endocrinology. 2005 Jan;146(1):375-82
references.pmid: 15459119
references.citation: J Clin Invest. 2000 Jul;106(2):171-6
references.pmid: 10903330
references.citation: Physiol Rev. 2006 Jan;86(1):205-43
references.pmid: 16371598
references.citation: J Clin Invest. 2005 Jul;115(7):1699-702
references.pmid: 16007246